NPS opposes Dong-A’s spin-off plan

Published: 2013-01-28 06:57:00

Updated: 2013-01-28 06:57:00

The National Pension Service (NPS), said Thursday that it opposes Dong-A Pharmaceutical’s plan to transform into a holding company, arguing it would only benefit the controlling family and undermine the interests of other shareholders.

The pension fund, a main shareholder of the drug producer ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK